Analysis of variance of 14 bioequivalence studies on 14 immediate-release, non-combinational, oral drugs. (DOCX 15Â kb
Country of residence distributions of the clinicians. Table S2. Publication type distributions of th...
Estimates for association between single nucleotide polymorphisms (SNPs) identified in genome-wide a...
Ranking of the different metrics computed for the Ambit dataset. Table S2. Ranking of the different ...
Average bioequivalence of 72-h-truncated area-under-the-concentration-time curve among three randoml...
Tutorial outlining the manual implementation of the DrugGenEx-NET methodology. (DOCX 14Â kb
Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...
Table S5. Prescription patterns of comorbidity-relevant medication according to sensitivity analyses...
Percent Coverage (percent convergence rate) for treatment effect, β1 for different approach, by num...
Comparison of compassionate use, humanitarian aid, off-label use and clinical trials. A table settin...
Table 4. Exclusions and justifications. A complete listing of all drugs excluded from analysis and ...
â Table S1: Drug pairs are sorted in a descending order of their interaction scores. â Table S2:...
Quality of reporting, percentage of items described by each cohort study. (PDF 31 kb
Median (Interquartile range (IQR)) absolute bias (%) for treatment effect, β1 for different approac...
Summary of included studies for adiposity. Table S2. Summary of included studies for motor developme...
Overview of methods for investigating variability in univariate meta-analysis [ 5, 6, 19â24 ]. Fig...
Country of residence distributions of the clinicians. Table S2. Publication type distributions of th...
Estimates for association between single nucleotide polymorphisms (SNPs) identified in genome-wide a...
Ranking of the different metrics computed for the Ambit dataset. Table S2. Ranking of the different ...
Average bioequivalence of 72-h-truncated area-under-the-concentration-time curve among three randoml...
Tutorial outlining the manual implementation of the DrugGenEx-NET methodology. (DOCX 14Â kb
Table S1. Pivotal trials with at least one postapproval trial with a patient-relevant outcome. (XLSX...
Table S5. Prescription patterns of comorbidity-relevant medication according to sensitivity analyses...
Percent Coverage (percent convergence rate) for treatment effect, β1 for different approach, by num...
Comparison of compassionate use, humanitarian aid, off-label use and clinical trials. A table settin...
Table 4. Exclusions and justifications. A complete listing of all drugs excluded from analysis and ...
â Table S1: Drug pairs are sorted in a descending order of their interaction scores. â Table S2:...
Quality of reporting, percentage of items described by each cohort study. (PDF 31 kb
Median (Interquartile range (IQR)) absolute bias (%) for treatment effect, β1 for different approac...
Summary of included studies for adiposity. Table S2. Summary of included studies for motor developme...
Overview of methods for investigating variability in univariate meta-analysis [ 5, 6, 19â24 ]. Fig...
Country of residence distributions of the clinicians. Table S2. Publication type distributions of th...
Estimates for association between single nucleotide polymorphisms (SNPs) identified in genome-wide a...
Ranking of the different metrics computed for the Ambit dataset. Table S2. Ranking of the different ...